Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8
Original Research
Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,183 | Dovepress* | 7,900+ | 1,494 | 9,394 | |
| PubMed Central* | 1,283 | 437 | 1,720 | ||
| Totals | 9,183 | 1,931 | 11,114 | ||
| *Since 19 September 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar